Alcami Forms Multi-year Partnership with Civica Rx
Per supply chain agreement, CDMO will provide analytical product support
Alcami, a contract development and manufacturing organization (CDMO), is partnering with Civica Inc. (Civica Rx), a nonprofit pharma company. Per the deal, Alcami will provide analytical support for products to be manufactured at Civica's 140,000 square-foot sterile injectable manufacturing facility in Petersburg, VA.
The CDMO’s network of laboratories across the US will support Civica's program with method establishment, validation, release, and stability for excipients, drug substances, and drug products, along with formulation development support.
"Alcami will provide testing services for products developed and manufactured for and at our Civica Petersburg manufacturing facility," says Martin VanTrieste, Civica Rx’s president and CEO. "Our partnership further strengthens our United States supply chain and supports our mission to make quality medicines accessible and affordable to everyone."
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
